{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-12-12T12:25:12.513207+00:00",
  "news": [
    {
      "title": "3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQY3FEWDdqcGp6N1pDLWIwZHVWMXhDd0xTTXNtSDZ4Rm85aVlLZE1VYkIyck5CYVVFdlI2WGNYM3dDdkJYUllZdnJfVUpPc1Y3QTVhYll5d0lFWllUM18tQ0RQWkswTVhEMkJTdjF5a1ZwbGRTcC1LWHg3eWdBRmhCMXk5OHhmdVkzV0NqbDZ5cUQteUhCQ2NJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxQY3FEWDdqcGp6N1pDLWIwZHVWMXhDd0xTTXNtSDZ4Rm85aVlLZE1VYkIyck5CYVVFdlI2WGNYM3dDdkJYUllZdnJfVUpPc1Y3QTVhYll5d0lFWllUM18tQ0RQWkswTVhEMkJTdjF5a1ZwbGRTcC1LWHg3eWdBRmhCMXk5OHhmdVkzV0NqbDZ5cUQteUhCQ2NJ?oc=5\" target=\"_blank\">3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-12-12T07:44:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex's gene therapy shows promise in younger children with blood disorders - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5\" target=\"_blank\">Vertex's gene therapy shows promise in younger children with blood disorders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-12-06T12:04:29+00:00",
      "source": "Reuters"
    },
    {
      "title": "Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdkNxRlVib3NYOHYzbXY5LUlmNFpCQUlyTUc1b2Y3SE9XWWdXUTBqcEY2clNpOVRnekxsMTROSjZuTHBoLVp1dkh1WEVVLV9HLWZnTWNhN0hUR2xFN3E4NmVtQUVZeUdJUW1VNi0tbzZFVkFpR3RKMFRqZmJjMGZuWHppb00tLUR5?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdkNxRlVib3NYOHYzbXY5LUlmNFpCQUlyTUc1b2Y3SE9XWWdXUTBqcEY2clNpOVRnekxsMTROSjZuTHBoLVp1dkh1WEVVLV9HLWZnTWNhN0hUR2xFN3E4NmVtQUVZeUdJUW1VNi0tbzZFVkFpR3RKMFRqZmJjMGZuWHppb00tLUR5?oc=5\" target=\"_blank\">Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2025-12-07T01:15:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQd0g4T3hlT04wT2E3VkRHZHk2cFVHQmZOamlLYm9oTE1oeWsyQWVqbHlycDhiS2Vva2ZnRzluYmJuWEJ1TjdubDZDa1JwVmxsMU4yWjlfTzlsazZwV3VQdFgwbkJBakJjUmdRb1lsUGZPbFBCMXZwaEN3SXNfdGFWZ1VKcnpjZWE2c0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxQd0g4T3hlT04wT2E3VkRHZHk2cFVHQmZOamlLYm9oTE1oeWsyQWVqbHlycDhiS2Vva2ZnRzluYmJuWEJ1TjdubDZDa1JwVmxsMU4yWjlfTzlsazZwV3VQdFgwbkJBakJjUmdRb1lsUGZPbFBCMXZwaEN3SXNfdGFWZ1VKcnpjZWE2c0E?oc=5\" target=\"_blank\">Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-27T08:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX): Assessing Valuation After a Strong Multi‑Quarter Run and Recent Pullback - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Assessing Valuation After a Strong Multi‑Quarter Run and Recent Pullback</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-10T11:39:11+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Wells Fargo Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $515 - 富途牛牛",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPS3FkdElwdldGUGxUenFTX2YxUi15RzRvSVVFR0VvOVhHdng2VmhuaTV6NHlicVdMNWY0Tm53b2xYMUNGMkFwQVdrRG5VSzF2ZUR0bG1NX0tBVGJqejcyYmFDQzhkdFdKLWxBeU8wRUF1YkJQX01xX1FadGRPbVlBMFFnVm5JQ216SnZRVy1NQVVfLXI5ZGQwUHRqLWtsV1Q1cGVxWVRuTVI2MWdhN2loOTdoZ2RkZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxPS3FkdElwdldGUGxUenFTX2YxUi15RzRvSVVFR0VvOVhHdng2VmhuaTV6NHlicVdMNWY0Tm53b2xYMUNGMkFwQVdrRG5VSzF2ZUR0bG1NX0tBVGJqejcyYmFDQzhkdFdKLWxBeU8wRUF1YkJQX01xX1FadGRPbVlBMFFnVm5JQ216SnZRVy1NQVVfLXI5ZGQwUHRqLWtsV1Q1cGVxWVRuTVI2MWdhN2loOTdoZ2RkZw?oc=5\" target=\"_blank\">Wells Fargo Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $515</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">富途牛牛</font>",
      "published": "2025-12-11T07:21:05+00:00",
      "source": "富途牛牛"
    },
    {
      "title": "Working at Vertex - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Working at Vertex</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Vertex Pharmaceuticals presents new data on CASGEVY at ASH - MSN",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNa0dudEtKaWZZdGJrd29yd3hHcnJMUG5NRzBHNTBpSnRGT3Izd0FQYk9tN3VzWmp3blJiRlFUWXRXaFpXR3UtaGxKRHhZRjBsNWNUMmp5QnBIOVNUWVZteUJBRW9rcGlTblFHb3o2dkp4VE5SODZmZUV1N1I2U0JReGhSSEstU01pWXdDQXpEOW42blNheHM5WGhMUjJ3NmRpQW5LLTlHSlZ3S01zVl83M2hCOGFLamUzNTh0LVlR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNa0dudEtKaWZZdGJrd29yd3hHcnJMUG5NRzBHNTBpSnRGT3Izd0FQYk9tN3VzWmp3blJiRlFUWXRXaFpXR3UtaGxKRHhZRjBsNWNUMmp5QnBIOVNUWVZteUJBRW9rcGlTblFHb3o2dkp4VE5SODZmZUV1N1I2U0JReGhSSEstU01pWXdDQXpEOW42blNheHM5WGhMUjJ3NmRpQW5LLTlHSlZ3S01zVl83M2hCOGFLamUzNTh0LVlR?oc=5\" target=\"_blank\">Vertex Pharmaceuticals presents new data on CASGEVY at ASH</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-12-08T08:22:28+00:00",
      "source": "MSN"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-11",
      "close": 445.92999267578125
    },
    "history": [
      {
        "date": "2025-12-03",
        "close": 463.1300048828125
      },
      {
        "date": "2025-12-04",
        "close": 457.3599853515625
      },
      {
        "date": "2025-12-05",
        "close": 455.4800109863281
      },
      {
        "date": "2025-12-08",
        "close": 442.0400085449219
      },
      {
        "date": "2025-12-09",
        "close": 437.010009765625
      },
      {
        "date": "2025-12-10",
        "close": 444.6400146484375
      },
      {
        "date": "2025-12-11",
        "close": 445.92999267578125
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}